NCT00877500 2025-11-10Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic TherapyM.D. Anderson Cancer CenterPhase 2 Active not recruiting116 enrolled